Atazanavir sulfate

This classification denotes a protease inhibitor with the molecular formula C38H52N6O7.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4MT4VIE29P, chemically known as 2,5,6,10,13-pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3s,8s,9s,12s)-, sulfate (1:1) (salt) but more generally known as atazanavir sulfate, which bears US NIH Compound Identifier 158550. European Medicines Agency schedules Atazanavir sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20595. Most nations, for tariff and trade purposes, schedule atazanavir sulfate under HS 29333999 and SITC 51574. As of Q4 2014, ATAZANAVIR SULFATE remains US FDA's Preferred Term for this commodity. Atazanavir sulfate bears US NLM identifiers UMLS ID C1176383 and NCI Concept Code C28835. SMILES: CC(C)(C)[C@@H](C(=O)N[C@@H](CC1CCCCC1)[C@H](CN(CC2CCC(CC2)C3CCCCN3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O.